⭐ The authority on professional skin care for over 50 years - Subscribe today! Subscribe Now

Myriad Genetics, Inc. recently announced that Janssen Research & Development, LLC

Please login to like posts.

📖 1 min read

Myriad Genetics, Inc. recently announced that Janssen Research & Development, LLC, will use Myriad’s BRACAnalysis test in connection with its Phase 3 clinical trial of Yondelis® (trabectedin) in the treatment of advanced-relapsed epithelial ovarian, primary peritoneal or fallopian tube cancers.

0 Comments

No comments yet. Be the first to comment!

Wait! Before You Go

Check out these exclusive offers you might be interested in